![3D Printed porous polyamide macrocapsule combined with alginate microcapsules for safer cell-based therapies | Scientific Reports 3D Printed porous polyamide macrocapsule combined with alginate microcapsules for safer cell-based therapies | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-26869-5/MediaObjects/41598_2018_26869_Fig1_HTML.jpg)
3D Printed porous polyamide macrocapsule combined with alginate microcapsules for safer cell-based therapies | Scientific Reports
![Sernova on X: "#ICYMI, an update from our Phase 1/2 study of our Cell Pouch with islet transplantation, our candidate in development for a potential 'functional cure' of insulin-dependent diabetes, was presented Sernova on X: "#ICYMI, an update from our Phase 1/2 study of our Cell Pouch with islet transplantation, our candidate in development for a potential 'functional cure' of insulin-dependent diabetes, was presented](https://pbs.twimg.com/media/FUmNwH8XoAACFA6.jpg)
Sernova on X: "#ICYMI, an update from our Phase 1/2 study of our Cell Pouch with islet transplantation, our candidate in development for a potential 'functional cure' of insulin-dependent diabetes, was presented
![Sernova in clinical development for functional cure of Type 1 Insulin-dependent diabetes - BioTuesdays Sernova in clinical development for functional cure of Type 1 Insulin-dependent diabetes - BioTuesdays](https://biotuesdays.com/wp-content/uploads/2021/01/2021-01-04_Sernova-pipeline-1024x475.jpg)
Sernova in clinical development for functional cure of Type 1 Insulin-dependent diabetes - BioTuesdays
![Sernova on X: "Our Cell Pouch System™ is a proprietary cell therapy platform being developed for the treatment of chronic diseases including insulin-dependent #diabetes, #HemophiliaA, and #hypothyroidism. Learn more: https://t.co/bTB5n9yiXO #T1D ... Sernova on X: "Our Cell Pouch System™ is a proprietary cell therapy platform being developed for the treatment of chronic diseases including insulin-dependent #diabetes, #HemophiliaA, and #hypothyroidism. Learn more: https://t.co/bTB5n9yiXO #T1D ...](https://pbs.twimg.com/media/F3vP1qEbAAAM45Q.jpg)
Sernova on X: "Our Cell Pouch System™ is a proprietary cell therapy platform being developed for the treatment of chronic diseases including insulin-dependent #diabetes, #HemophiliaA, and #hypothyroidism. Learn more: https://t.co/bTB5n9yiXO #T1D ...
![Sernova taps Evotec's insulin-producing cells to fill its pouch implant for diabetes | Fierce Biotech Sernova taps Evotec's insulin-producing cells to fill its pouch implant for diabetes | Fierce Biotech](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1621963401/Screen%20Shot%202020-06-27%20at%204.30.11%20PM.png/Screen%20Shot%202020-06-27%20at%204.30.11%20PM.png?VersionId=y6XmytPtaAmdS9_.cZm_zu6tInA0VYSL)
Sernova taps Evotec's insulin-producing cells to fill its pouch implant for diabetes | Fierce Biotech
![Dr Philip Toleikis, Sernova, Cell Pouch technology, islet cell transplants, glucose responsive techn Dr Philip Toleikis, Sernova, Cell Pouch technology, islet cell transplants, glucose responsive techn](https://view.pagetiger.com/desang-magazine/Issue78-Apr17/Thumbs/Page_1704270819001_0020-800-0-0.jpg)
Dr Philip Toleikis, Sernova, Cell Pouch technology, islet cell transplants, glucose responsive techn
![Sernova and Evotec on Track to Initiate Clinical Testing of First iPSC-Derived Islets as a Potential Functional Cure for Type 1 Diabetes | BioInformant Sernova and Evotec on Track to Initiate Clinical Testing of First iPSC-Derived Islets as a Potential Functional Cure for Type 1 Diabetes | BioInformant](https://bioinformant.com/wp-content/uploads/2023/01/first-ipsc-derived-islets-in-cell-pouch.png)